Bank Of Montreal Vir Biotechnology, Inc. Transaction History

Bank Of Montreal

  • $191 Billion
  • Q1 2024

A detailed history of Bank Of Montreal transactions in Vir Biotechnology, Inc. stock. As of the latest transaction made, Bank Of Montreal holds 20,885 shares of VIR stock, worth $185,876. This represents 0.0% of its overall portfolio holdings.

Number of Shares
20,885
Previous 14,672 42.35%
Holding current value
$185,876
Previous $147,000 43.54%
% of portfolio
0.0%
Previous 0.0%

Shares

10 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024
BUY
$8.6 - $11.9 $53,431 - $73,934
6,213 Added 42.35%
20,885 $211,000
Q4 2023

Feb 08, 2024
SELL
$7.76 - $10.29 $5,579 - $7,398
-719 Reduced 4.67%
14,672 $147,000
Q3 2023

Nov 01, 2023
BUY
$9.14 - $24.62 $35,115 - $94,590
3,842 Added 33.27%
15,391 $144,000
Q2 2023

Aug 02, 2023
BUY
$23.2 - $27.29 $31,691 - $37,278
1,366 Added 13.41%
11,549 $283,000
Q1 2023

Jun 13, 2024
SELL
$22.26 - $30.85 $183,555 - $254,389
-8,246 Reduced 39.48%
12,639 $294,000
Q4 2022

Feb 01, 2023
SELL
$19.96 - $28.22 $1,796 - $2,539
-90 Reduced 0.88%
10,183 $257,000
Q3 2022

Nov 10, 2022
BUY
$18.26 - $31.1 $38,930 - $66,305
2,132 Added 26.19%
10,273 $308,000
Q2 2022

Aug 11, 2022
BUY
$19.08 - $26.7 $155,330 - $217,364
8,141 New
8,141 $217,000
Q4 2021

Feb 11, 2022
SELL
$30.97 - $54.03 $6.38 Million - $11.1 Million
-205,896 Closed
0 $0
Q3 2021

Nov 12, 2021
BUY
$34.9 - $54.54 $7.19 Million - $11.2 Million
205,896 New
205,896 $8.93 Million

Others Institutions Holding VIR

# of Institutions
225
Shares Held
88.2M
Call Options Held
177K
Put Options Held
182K
View Full List

About Vir Biotechnology, Inc.

VIR Quotes by TradingView
  • Ticker VIR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 132,638,000
  • Market Cap $1.18B
  • Description
  • Vir Biotechnology, Inc., a commercial-stage immunology company, develops therapeutic products to treat and prevent serious infectious diseases. It develops Sotrovimab (VIR-7832), a SARS-CoV-2-neutralizing mAbs to treat and prevent COVID-19 infection under the Xevudy brand; VIR-2218 and VIR-3434 for the treatment of hepatitis B virus; VIR-2482 fo...
More about VIR
Track This Portfolio

Track Bank Of Montreal Portfolio

Follow Bank Of Montreal and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of Montreal , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of Montreal with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email